Introduction of cyclofem® once-a-month injectable contraceptive in Mexico

Contraception

Volumn 58, Issue 1, 1998, Pages 7-12

  Garza Flores, J ^a   Morales Del Olmo, A ^a   Fuziwara, J L ^a   Figueroa, J G ^b   Alonso, A ^b   Monroy, J ^b   Perez, M ^b   Urbina Fuentes, M ^b   Guevara, S J ^a   Cedeno, E ^c   Barrios, R ^c   Ferman, J J ^c   Medina, L M ^c   Velazquez, E ^c   Perez Palacios, G ^a,b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

^c Servicios Coordinados Salud E   (Mexico)

Author keywords

Cyclofem; Introductory study; Mexico; Once a month injectable contraception

Indexed keywords

ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE; CONTRACEPTIVE AGENT; DRUG DERIVATIVE; ESTRADIOL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

AMENORRHEA; ARTICLE; BLEEDING; CLINICAL TRIAL; COMMUNITY; CONTRACEPTION; COUNSELING; DRUG SAFETY; FEMALE; FOLLOW UP; HEALTH CENTER; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MEXICO; PREGNANCY RATE; ADOLESCENT; ADULT; CLINICAL RESEARCH; CONTRACEPTION CONTINUATION; CONTRACEPTION TERMINATION; CONTRACEPTIVE AGENTS, FEMALE--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS, PROGESTIN--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS--PHARMACODYNAMICS; CONTRACEPTIVE EFFECTIVENESS; CONTRACEPTIVE METHODS; CONTRACEPTIVE USAGE; DEVELOPING COUNTRY; EDUCATIONAL STATUS; FAMILY PLANNING; INJECTABLES; MEDROXYPROGESTERONE ACETATE--PHARMACODYNAMICS; METHODOLOGY; NORTH AMERICA; PATIENT SATISFACTION; PROSPECTIVE STUDY; RESEARCH REPORT; SOUTH AND CENTRAL AMERICA; WESTERN HEMISPHERE;

AMERICAS; CLINICAL RESEARCH; CONTRACEPTION; CONTRACEPTION CONTINUATION; CONTRACEPTION TERMINATION; CONTRACEPTIVE AGENTS, FEMALE--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS, PROGESTIN--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS--PHARMACODYNAMICS; CONTRACEPTIVE EFFECTIVENESS; CONTRACEPTIVE METHODS; CONTRACEPTIVE USAGE; DEVELOPING COUNTRIES; FAMILY PLANNING; INJECTABLES; LATIN AMERICA; MEDROXYPROGESTERONE ACETATE--PHARMACODYNAMICS; MEXICO; NORTH AMERICA; RESEARCH METHODOLOGY; RESEARCH REPORT;

ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, COMBINED; EDUCATIONAL STATUS; ESTRADIOL; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MEDROXYPROGESTERONE 17-ACETATE; MEXICO; PATIENT SATISFACTION; PROSPECTIVE STUDIES;

EID: 0032123544     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(98)00062-6     Document Type: Article

References (17)

1. Facts about once-a-month injectable contraceptives memorandum from a WHO meeting . Bull WHO. 70:1993;677-689.
2. Coutinho E.M., De Souza J.C. Conception control by monthly injections of medroxyprogesterone suspension and a long-acting oestrogen. J Reprod Fertil. 15:1968;209-214.
3. Aedo A.R., Landgren B.M., Johannisson E., Diczfalusy E. Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations. Contraception. 31:1985;453-469.
4. Hall PE. Long-acting injectable formulations. In: Diczfalusy E, Bygdeman M, eds. Fertility regulation today and tomorrow. Raven Press, New York: Serono Symposia Publications, 1987:119-41.
5. Fotherby K., Benagiano G., Toppozada H.K., et al. A preliminary pharmacological trial of the monthly injectable contraceptive Cycloprovera. Contraception. 25:1982;261-272.
6. Bassol S., Garza-Flores J., Cravioto M.C., et al. Ovarian function following a single administration of depomedroxyprogesterone acetate (DMPA) at different doses. Fertil Steril. 42:1984;215-222.
7. Garza-Flores J. Pharmacokinetics of once-a-month injectable contraceptives. Contraception. 49:1994;347-359.
8. Bassol S., Garza-Flores J. Review of ovulation return upon discontinuation of once-a-month injectable contraceptives. Contraception. 49:1994;441-453.
9. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids norethisterone oenanthate and medroxyprogesterone acetate. 1. Use-effectiveness . Contraception. 15:1977;513-533.
10. A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection I. Contraceptive efficacy and side-effects . Contraception. 37:1988;1-20.
11. A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection II. The comparison of bleeding patterns . Contraception. 40:1989;531-551.
12. Farley T.M.M. Life table methods for contraceptive research. Stat Med. 5:1986;475-489.
13. Task Force on Long-Acting Systemic Agents for the Regulation of Fertility. A multicentred pharmacokinetic, pharmacodynamic study of once-a-month injectable contraceptives. I. Different doses of HRP-112 and of Depo Provera. Contraception. 36:1987;441-457.
14. Garza-Flores J., Hall P.E., Perez-Palacios G. Long-acting hormonal contraceptives for women. J Steroid Biochem Mol Biol. 40:1991;697-704.
15. Garza-Flores J., Hall P.E., Sang G.-W. Population and delivery systems variability in the pharmacokinetics of long-acting injectable contraceptives . Snow R.C., Hall P.E. Steroid Contraceptives and Women's Response Regional Variability in Side Effects and Pharmacokinetics . 1994;69-83 Plenum Press, New York.
16. Task Force on Research on Introduction and Transfer of Technologies for Fertility Regulation. The introduction of Cyclofem into national family planning programs experience from studies in Indonesia, Jamaica, Mexico, Thailand and Tunisia . Contraception. 49:1994;489-507.
17. Garza-Flores J., Rodriguez V., Cravioto M.C., et al. Eficacia de anticonceptivos inyectables en mujers mexicanas. Bol Of Sanit Panam. 98:1985;181-186.